| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 248.32 |
| Log P | RDKit | 2.76 |
| Topological polar surface area (Å2) | RDKit | 38.83 |
| Number of hydrogen bond acceptors | RDKit | 3 |
| Number of hydrogen bond donors | RDKit | 0 |
| Number of carbon atoms | RDKit | 15 |
| Number of heavy atoms | RDKit | 18 |
| Number of heteroatoms | RDKit | 3 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 4 |
| Stereochemical complexity | RDKit | 0.27 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 5 |
| Number of sp3 hybridized carbon atoms | RDKit | 10 |
| Shape complexity | RDKit | 0.67 |
| Number of rotatable bonds | RDKit | 0 |
| Number of aliphatic carbocycles | RDKit | 1 |
| Number of aliphatic heterocycles | RDKit | 2 |
| Number of aliphatic rings | RDKit | 3 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 3 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 2 |
| Number of saturated rings | RDKit | 2 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 3 |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Good |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.286237 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -6.15 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 3 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |
| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | NPASS |
| TAR_EXP_000845 | ENSG00000166949 | SMAD3 | 4088 | ChEMBL, NPASS |
| TAR_EXP_000747 | ENSG00000138413 | IDH1 | 3417 | ChEMBL, NPASS |
| TAR_EXP_000554 | ENSG00000101347 | SAMHD1 | 25939 | ChEMBL |
| TAR_EXP_000411 | ENSG00000165092 | ALDH1A1 | 216 | ChEMBL, NPASS |
| TAR_EXP_000097 | ENSG00000108468 | CBX1 | 10951 | NPASS |
| TAR_EXP_000095 | ENSG00000224143 | EHMT2 | 10919 | ChEMBL, NPASS |
| TAR_EXP_000004 | ENSG00000094631 | HDAC6 | 10013 | ChEMBL |
| TAR_EXP_000968 | ENSG00000109320 | NFKB1 | 4790 | ChEMBL |
| TAR_EXP_001206 | ENSG00000042088 | TDP1 | 55775 | ChEMBL, NPASS |
| TAR_EXP_001300 | ENSG00000160801 | PTH1R | 5745 | NPASS |
| TAR_EXP_001362 | ENSG00000173039 | RELA | 5970 | ChEMBL |
| TAR_EXP_001366 | ENSG00000117152 | RGS4 | 5999 | NPASS |
| TAR_EXP_001614 | ENSG00000136869 | TLR4 | 7099 | BindingDB |
| TAR_EXP_001665 | ENSG00000111424 | VDR | 7421 | ChEMBL, NPASS |
| TAR_EXP_001711 | ENSG00000187555 | USP7 | 7874 | BindingDB |
| TAR_EXP_001031 | ENSG00000112312 | GMNN | 51053 | ChEMBL, NPASS |
| TAR_EXP_000969 | ENSG00000077150 | NFKB2 | 4791 | ChEMBL |
